Survival outcomes among colorectal cancer patients at Kenyatta National Hospital: A retrospective cohort study.
Amsalu DeguPeter N KarimiSylvia A OpangaDavid G NyamuPublished in: Cancer reports (Hoboken, N.J.) (2022)
A retrospective cohort study was employed among 232 eligible medical records of colorectal cancer patients. Simple random sampling was used to select the medical records of the patients. The included medical records of the study participants were followed up retrospectively from the date of primary cancer diagnosis until the last visit to the hospital. All relevant data, such as sociodemographics, clinical characteristics, and outcome-measuring parameters, were recorded in the predesigned data abstraction tool by reviewing the documented clinical records of the patients. The data were entered and analyzed using International Business Machines (IBM) Statistical Package for the Social Sciences (SPSS) version 26 software. Mean, median, standard deviation, frequency tables, and figures were used to present the data. Kaplan Meier analyses were employed to determine survival outcomes. The mean age of the study participants was 54.1 ± 13.3 years, and the majority were males (126, 54.3%). Almost a third (34.1%) of patients had evidence of disease progression despite treatment in the follow-up period, with 7.8% showing no response to therapy and 23.6% experiencing new distant metastasis. The survival rate dwindled from the first year (87.9%) to the fifth year (45.4%), and the mortality rate was 22.8% CONCLUSION: There was a high mortality rate, disease progression, and distant metastasis in the last follow-up period suggesting the need to strengthen the healthcare system by ensuring access to prevention, early diagnosis, and optimal treatment of colorectal cancer.
Keyphrases
- end stage renal disease
- healthcare
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- squamous cell carcinoma
- lymph node
- type diabetes
- electronic health record
- mental health
- risk factors
- quality improvement
- stem cells
- coronary artery disease
- replacement therapy
- patient reported
- mesenchymal stem cells
- papillary thyroid
- acute care
- cell therapy
- bone marrow